找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiac Arrhythmias; Diagnosis Prognosis M. Schlepper,B. Olsson Conference proceedings 1983 Springer-Verlag Berlin Heidelberg 1983 arrhyth

[復制鏈接]
樓主: Kennedy
11#
發(fā)表于 2025-3-23 11:16:06 | 只看該作者
12#
發(fā)表于 2025-3-23 16:38:13 | 只看該作者
Computers in Nursing Administrationoactively labeled substances. In earlier studies by Wiebringhaus, Keller, and Blanke et al. in Düsseldorf, Berlin, and G?ttingen and in our research center in Ludwigshafen, the method used allowed sufficiently precise determinations only above a concentration of 200 ng/ml, which left some uncertaint
13#
發(fā)表于 2025-3-23 21:41:49 | 只看該作者
14#
發(fā)表于 2025-3-24 00:04:05 | 只看該作者
https://doi.org/10.1007/978-1-4612-2182-1veral coexisting diseases. Thus, the danger of drug interaction — a potentiation or diminution of effect — exists for a large patient population whose number is beyond estimation. Obviously, the innumerable possibilities of drug combination make a systemic investigation of interaction impossible. It
15#
發(fā)表于 2025-3-24 05:18:07 | 只看該作者
https://doi.org/10.1007/978-1-4039-3734-6therapy now than previously. Lidocaine is the drug normally used in patients with acute myocardial infarction and ventricular arrhythmias; however, it can be given only by intravenous infusion. Therefore, drugs with specific antiarrhythmic action which can also be administered orally add to the ther
16#
發(fā)表于 2025-3-24 08:00:41 | 只看該作者
Sherrill Snelgrove,David Hughes chemical formula is 2′-(2-hydroxy-3-propylaminopropoxy)-3-phenylpropiophenone hydrochloride. It is available in the form of 150- and 300 mg oral tablets and as a parenteral preparation (70 mg per vial). The antiarrhythmic properties of this drug were reported by the Berlin Pharmaceutical Institute
17#
發(fā)表于 2025-3-24 13:33:02 | 只看該作者
Katrina Singhatey,Moira GoodmanIf one wants to discuss the value of programmed stimulation of the heart to study mechanisms and treatment of tachycardias, it is helpful to divide the patient population into three groups:
18#
發(fā)表于 2025-3-24 18:46:30 | 只看該作者
Mary L. McHugh,Samuel Schultz IISome aspects of the clinical pharmacology of propafenone are presented in other reports in this volume. This chapter will therefore be limited to a discussion of clinicoelectrophysiological findings and to questions of clinical effectiveness and the occurrence of side effects.
19#
發(fā)表于 2025-3-24 21:18:00 | 只看該作者
People with infectious diseases,The aim of this study was to test the efficacy and tolerability of propafenone and disopyramide (Rhythmodan) in the treatment of ventricular premature beats (VPBs) in a double-blind experiment.
20#
發(fā)表于 2025-3-25 01:12:07 | 只看該作者
Results of Invasive Methods,If one wants to discuss the value of programmed stimulation of the heart to study mechanisms and treatment of tachycardias, it is helpful to divide the patient population into three groups:
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2026-1-27 02:52
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
玛纳斯县| 海伦市| 安仁县| 大同市| 贺州市| 敦煌市| 佛冈县| 芜湖县| 松滋市| 福建省| 色达县| 桑植县| 如皋市| 微博| 成都市| 资阳市| 章丘市| 厦门市| 富裕县| 安龙县| 含山县| 馆陶县| 卢氏县| 西吉县| 谷城县| 新丰县| 师宗县| 磴口县| 定安县| 沁源县| 社旗县| 南雄市| 巴东县| 德州市| 余干县| 吉隆县| 渑池县| 宁陵县| 都安| 错那县| 大宁县|